Dr. Priyom Bose

Omicron binds to ACE2 with high affinity, enhancing its transmissibility and infectivity

Does a COVID-19 vaccine booster improve the immune response of a poor responder?

A new study has focussed on determining the levels of nAb in individuals who received the second and third doses of the RNA vaccines developed by Pfizer and Moderna.

SARS-CoV-2 surveillance in urban wildlife from Ontario and Québec

Researchers conducted SARS-CoV-2 surveillance in urban wildlife from Ontario and Québec, Canada.

Inequalities of the US COVID-19 vaccination drive

The percentage of individuals with at least one dose of a COVID-19 vaccine, by communities, were collected from eight cities to determine US vaccine inequality.

Forecasting outbreak of SARS-CoV-2 Omicron variant with Tajima's D

A new study argues that that rapid genomic sequence surveillance is absolutely crucial and Tajima D tests should be included to predict future COVID-19 outbreaks.

Evaluating comparative effectiveness of Pfizer-BioNtech and Moderna vaccines among US veterans

A new study provided evidence of a lower 24-week risk of COVID-19–related outcomes among recipients of the mRNA-1273 vaccine, compared to their counterparts who received the BNT162b2 vaccine.

Effectiveness of COVID-19 vaccines in New York State

A new study reports that BNT162b2 booster doses are safe and have shown enhancement in short-term protection against the Delta variant.

Systematic survey of human SARS-CoV-2 monoclonal antibodies

Scientists have mined information from several research publications and patents to create a dataset of approximately 8000 human antibodies to the SARS-CoV-2 spike from more than 200 donors.

Study suggests efficacy of SARS-CoV-2 main protease inhibitors is not compromised in current COVID-19 variants

A new study has focussed on assessing the Mpro mutants of newly emerged SARS-CoV-2 variants.

COVID-19 vaccination status based infection likelihood in New Zealand

A new study has determined the possible number of infections caused by an unvaccinated versus vaccinated individual.